基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the full record of transactions filed by Sukhtian Ghiath M., 董事. Director active across 1 company, notably Outlook Therapeutics, Inc.. Aggregated, 8 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €19.9m. Activity tracked since 29 November 2021. The latest transaction was disclosed on 12 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Sukhtian Ghiath M. is Administrateur and Director of Outlook Therapeutics, Inc. He has filed 8 filings in total, and across the sampled recent filings, purchases total 19875799 EUR and sales total 0 EUR, over the period from 2021-12-01 to 2026-08-14. The most frequent transaction nature listed is Attribution.